Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Step down heating and melphalan: cytotoxic interactions and clinical implications

F d'Oleire1, M E Kutz, A Bird

  • 1University of Wisconsin Department of Human Oncology, Madison 53792-6164.

Melanoma Research
|October 1, 1994
PubMed
Summary

Step down hyperthermia enhances melphalan chemotherapy in sarcoma cells. Even short heat exposures significantly increase melphalan

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Provenance of late Pleistocene loess in central and eastern Europe: isotopic evidence for dominant local sediment sources.

Scientific reports·2025
Same author

Using morphometrics to identify sex in the eastern blue-tongued skink (Tiliqua scincoides).

Australian veterinary journal·2023
Same author

Blood product utilisation for coronary artery bypass graft surgery at a public and a private hospital in Western Cape Province, South Africa.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2021
Same author

Large volume reirradiation after progression on bevacizumab.

Neuro-oncology practice·2019
Same author

Correction: Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.

PloS one·2016
Same author

Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.

PloS one·2016

Area of Science:

  • Oncology
  • Biophysics

Background:

  • Hyperthermia, or heat therapy, is explored as an adjunct to chemotherapy.
  • Melphalan is a chemotherapeutic agent used in cancer treatment.
  • Understanding heat's effect on chemotherapy efficacy is crucial for optimizing treatment protocols.

Purpose of the Study:

  • To investigate the in vitro effects of step-down hyperthermia on L929 sarcoma cells.
  • To determine the synergistic effects of hyperthermia and melphalan on cancer cell killing.
  • To evaluate the thermal enhancement ratios (TER) of melphalan under different hyperthermia durations.

Main Methods:

  • In vitro study using L929 sarcoma cells.
  • Application of step-down heating protocols (41.8°C decreasing to 40.5°C for 10, 15, and 20 minutes).

Related Experiment Videos

  • Co-administration of varying doses of melphalan with hyperthermia.

    • Main Results:

    • Step-down heating for 20 minutes at 41.8°C showed equivalent cell killing to prolonged heating (41.8°C x 65 min).
    • Significant heat enhancement of melphalan was observed at all tested durations (10, 15, and 20 min).
    • Thermal enhancement ratios (TER) ranged from 8.3 to 10.3, indicating substantial synergy between heat and melphalan.

    Conclusions:

    • Step-down hyperthermia, even for short durations, can significantly enhance the efficacy of melphalan in sarcoma cells.
    • These findings support the potential application of hyperthermic limb perfusions in combination with chemotherapy for treating sarcomas and melanomas.
    • Optimized hyperthermia protocols may improve treatment outcomes for specific cancers.